Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Insight into Infectious Diseases Could Lead to Preventive Vaccines for Some Rheumatic Illnesses

Thomas R. Collins  |  Issue: August 2016  |  August 11, 2016

Research is showing the potential role of infectious agents in rheumatic diseases.

Research is showing the potential role of infectious agents in rheumatic diseases.
science photo/shutterstock.com

CHICAGO—Medicine is in the middle of an infectious-disease “revolution” that seems almost destined to lead to prevention through immunization of many diseases, including rheumatic illnesses, that never were previously thought to involve transmissible agents, an infectious disease specialist said in a session at the ACR’s 2016 State-of-the-Art Clinical Symposium.

An array of unlikely and fascinating connections between infections and diseases have been discovered over the past several decades—links of viruses and cancer, the discovery that the key to peptic ulcer disease isn’t acid, but the bacterium Helicobacter pylori, to name a couple of examples. And the rate of research in this area is mushrooming, said Bennett Lorber, MD, MACP, professor of medicine at the Lewis Katz School of Medicine at Temple University.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A Paradigm Shift

Dr. Lorber

Dr. Lorber

“There’s been a giant paradigm shift in our understanding of the relationship between microorganisms and human beings,” said Dr. Lorber, who himself is barely able to contain his excitement at some of the amazing findings. “We’re in the middle of a scientific revolution.”

One of the more incredible discoveries was the Nobel Prize-winning discovery that what appeared to be a neurodegenerative disease, Kuru, in people who live in the highlands of Papua New Guinea, was actually a transmissible disease with an incubation period of years or decades. The highlanders honor their dead by eating them, and the disease was being transmitted this way: Those who prepared or ate the brains of the dead had the highest rates of attack.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Spongiform encephalopathies, like Kuru, are caused by tiny bits of protein with no nucleic acid, or prions, a discovery so contrary to conventional science it was “heretical,” Dr. Lorber said. The discovery won Stanley Prusiner, MD, the Nobel Prize in 1997.

In PANDAS—pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections—children who get strep throat within two months have a dramatic onset of obsessive compulsive disorder, and those with OCD suddenly worsen. Penicillin prophylaxis helps with this, Dr. Lorber said.

Infectious Agents

The potential role of infectious agents can be seen in rheumatic diseases, as well.

People with rheumatoid arthritis have periodontal diseases more often, and worse cases of it, than controls. The major cause of periodontitis is the bacterium Porphyromonas gingivalis, which produces arginine proteinases that it needs in order to live in gingival crevices. One of these proteinases, peptidylarginine deiminase, coverts arginine to citrulline. Of course, people with RA have antibodies to cyclic citrullinated peptides.1

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:2016 State-of-the-Art Clinical SymposiumImmunizationinfectious diseasepreventiveResearchRheumatic DiseaseTreatmentvaccine

Related Articles

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA

    September 17, 2019

    Researchers know human leukocyte antigen (HLA) molecules affect susceptibility to disease in general, and immunological disease in particular. In the case of ankylosing spondylitis (AS), the risk is primarily associated with HLA-B27, with smaller effects from other HLA alleles. Current thinking is that AS is caused by the presence of a genetically primed host because…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences